MetaCap

Genprex (GNPX) vs Revelation Biosciences (REVB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Revelation Biosciences is the larger company by market cap ($2.0 million vs $1.9 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GNPX-44.66%REVB+322.65%
+459%+195%-69%
Oct 7, 20261 yearNov 20, 2026
GNPX-46.69%REVB+360.59%
+487%+207%-72%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GNPX versus REVB key metrics
MetricGNPXREVB
Share price$1.45$3.50
Market cap$1.94M$1.99M
1-day change-13.17%-5.15%
P/E ratio (TTM)0.01—
EPS (TTM)$98.47$-99.96
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-16.23M$-8.91M
52-week high$80.96$40.60
52-week low$1.45$3.08
Distance from 52-week high-98.21%-91.38%
Analyst consensus—none
Avg. price target upside—+407.14%
Average volume168.88K12.49K
Shares outstanding1.33M569.06K
Employees138
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Genprex

GNPX stock →

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.

Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees

About Revelation Biosciences

REVB stock →

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.

Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees

GNPX vs REVB FAQ

Which is bigger, Genprex or Revelation Biosciences?

Revelation Biosciences (REVB) is larger, with a market capitalization of $1.99M compared with $1.94M for Genprex (GNPX).

Are Genprex and Revelation Biosciences in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons